Locus Pharmaceuticals

Broad U.S. patent issued for computational drug design technology

Published in Drug Law Weekly, June 15th, 2004

Locus Pharmaceuticals announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 6,735,530 B1, entitled "Computational Protein Probing to Identify Binding Sites," on May 11, 2004.

The patent protects an innovative computational method for the design of new drugs. Locus' proprietary core technology rapidly calculates the affinity of small molecule fragments, selected from Locus' proprietary fragment database, to allow accurate mapping of the surface of targeted proteins. From such information, Locus scientists identify viable drug binding sites and computationally design and synthesize new drug molecules for the target protein.

This...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2004-06-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry